Literature DB >> 10072906

Several new targets of antitumor agents.

X W Wang1, B Xu.   

Abstract

Alpha-fetoprotein (AFP), as a hepatoma-promoting factor, has become a new target of anti-hepatoma agents. It is a new approach for the treatment of tumors to inhibit or block oncogene expression. Informational drugs are being developed for gene therapy applications as inhibitors of oncogene expression. The induction of tumor cell differentiation is another new strategy of drug therapy of tumors. Common action mode of many antitumor drugs is to induce apoptosis of tumor cells. Suicide genes, as targeting therapy of tumors, improve the present chemotherapy, exhibiting broad application prospects.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 10072906

Source DB:  PubMed          Journal:  Zhongguo Yao Li Xue Bao        ISSN: 0253-9756


  5 in total

1.  Growth inhibition of human liver cancer cells by alpha-fetoprotein antisense strategy.

Authors:  X W Wang; H Xie
Journal:  In Vitro Cell Dev Biol Anim       Date:  1999-03       Impact factor: 2.416

2.  Antihepatoma effect of alpha-fetoprotein antisense phosphorothioate oligodeoxyribonucleotides in vitro and in mice.

Authors:  X W Wang; J H Yuan; R G Zhang; L X Guo; Y Xie; H Xie
Journal:  World J Gastroenterol       Date:  2001-06       Impact factor: 5.742

3.  Expression of alpha fetoprotein messenger RNA in BEL-7404 human hepatoma cells and effect of L-4 oxalysine on the expression.

Authors:  Xing-Wang Wang; Bin Xu
Journal:  World J Gastroenterol       Date:  1998-08       Impact factor: 5.742

4.  Effects of tachyplesin on proliferation and differentiation of human hepatocellular carcinoma SMMC-7721 cells.

Authors:  Gao-Liang Ouyang; Qi-Fu Li; Xuan-Xian Peng; Qing-Rong Liu; Shui-Gen Hong
Journal:  World J Gastroenterol       Date:  2002-12       Impact factor: 5.742

5.  Construction of a targeting adenoviral vector carrying AFP promoter for expressing EGFP gene in AFP-producing hepatocarcinoma cell.

Authors:  Yu-Jun Shi; Jian-Ping Gong; Chang-An Liu; Xu-Hong Li; Ying Mei; Can Mi; Yan-Ying Huo
Journal:  World J Gastroenterol       Date:  2004-01-15       Impact factor: 5.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.